Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy-Reference-Cited by-同舟云学术

Fibroblast growth factor 19 as a countermeasure to muscle and locomotion dysfunctions in experimental cerebral palsy

Published:2021-10-26 Issue:6 Volume:12 Page:2122-2133
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J cachexia sarcopenia muscle

Author:

Pereira Sabrina da Conceição¹^ORCID,Benoit Bérengère²^ORCID,Aguiar Junior Francisco Carlos Amanajás³^ORCID,Chanon Stéphanie²^ORCID,Vieille‐Marchiset Aurélie²^ORCID,Pesenti Sandra²,Ruzzin Jérome⁴^ORCID,Vidal Hubert²^ORCID,Toscano Ana Elisa¹⁵^ORCID

Affiliation:

1. Studies in Nutrition and Phenotypic Plasticity Unit, Department of Nutrition Federal University of Pernambuco Recife Pernambuco Brazil

2. CarMeN laboratory, French National Institute of Health and Medical Research (INSERM) U1060, National Research Institute for Agriculture, Food and Environment (INRAE) U1397 University of Lyon, Claude Bernard University Lyon 1 Oullins France

3. Biotechnology and Pharmaceuticals Laboratory, CAV Federal University of Pernambuco Vitória de Santo Antão Pernambuco Brazil

4. Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine University of Oslo Oslo Norway

5. Department of Nursing, CAV Federal University of Pernambuco Vitória de Santo Antão Pernambuco Brazil

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12819

Reference37 articles.

1. Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. National Surveys, 2011–2013

2. Cerebral palsy: an overview;Gulati S;Indian J Pediatr,2017

3. Chronic disease risk among adults with cerebral palsy: the role of premature sarcopoenia, obesity and sedentary behaviour

4. Bone health in cerebral palsy: Who's at risk and what to do about it?

5. Perspective: cerebral palsy as a model of bone development in the absence of postnatal mechanical factors;Ward KA;J Musculoskelet Neuronal Interact,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neonatal high-dose riboflavin treatment channels energy expenditure towards sensorimotor and somatic development and reduces rodent growth and weight gain by modulating NRF-1 in the hypothalamus;Physiology & Behavior;2024-12

2. Early intensive rehabilitation reverses locomotor disruption, decrease brain inflammation and induces neuroplasticity following experimental Cerebral Palsy;Brain, Behavior, and Immunity;2024-10

3. Neonatal resveratrol treatment in cerebral palsy model recovers neurodevelopment impairments by restoring the skeletal muscle morphology and decreases microglial activation in the cerebellum;Experimental Neurology;2024-08

4. Identification of potential biomarkers for cerebral palsy and the development of prediction models;Experimental Biology and Medicine;2024-07-09

5. Early-life malnutrition role in memory, emotional behavior and motor impairments in early brain lesions with potential for neurodevelopmental disorders: a systematic review with meta-analysis;Nutritional Neuroscience;2024-07-04